BACH BOLIGCENTER ApS: Financial statements 2022
CVR: 12024584
Source: annual report 2022, Danish Business Authority
01/05/2021 – 30/04/2022
BACH BOLIGCENTER ApS (CVR 12024584) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -13,574 and a net result of DKK -153,237 compared with DKK -8,961 the year before. Equity in the 2022 report amounted to DKK 682,284. The solvency ratio was 97.1%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -13,574
- Profit/Loss
- DKK -153,237
- Equity
- DKK 682,284
- Total Assets
- DKK 702,561
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -14K | -153K | 682K | 1 |
| 2021 | - | -13K | -9K | 892K | 1 |
| 2020 | - | -14K | -166K | 956K | 0 |
| 2019 | - | -17K | 12K | 1.2M | 1 |
| 2018 | - | -18K | 9K | 1.2M | - |
Official annual report
Keep an eye on BACH BOLIGCENTER ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout BACH BOLIGCENTER ApS
BACH BOLIGCENTER ApS is a Danish company of the type Anpartsselskab based in Hammel, founded in 1988. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named EMBRYODAN ApS. The management consists of Geo Koch. The company is owned by Geo Koch. The company has 1 employee (2023). In 2026, the company reported a gross profit of DKK -12,635 and a net result of DKK 3,958 compared with DKK -35,885 the year before. Equity in the 2026 report amounted to DKK 243,122.
